Table 3.
Comparison of p16 staining in the previous reports and the present study
| Author | Nondysplastic* | CIN1 | CIN2 | CIN3 |
|---|---|---|---|---|
| Klaes et al.5 (2002) | 7.58 (12%) | 15.17 (88%) | 10.10 (100%) | 43.43 (100%) |
| Benevolo et al.16 (2006) | 0.17 (0%) | 17.54 (31%) | 9.10 (90%) | 11.11 (100%) |
| Ishikawa et al.20 (2006) | 0.7 (0%) | 13.53 (25%) | 32.40 (80%) | 45.48 (94%) |
| Focchi et al.21 (2007) | 0.114 (0%) | 80.88 (91%) | 33.33 (100%) | 32.32 (100%) |
| Ikeda et al.13 (2008) | - | 29.39 (74.4%) | 29.31 (93.5%) | 42.43 (97.7%) |
| Reuschenbach et al.3 (2010) | 0.21 (0%) | 12.21 (57.1%) | 17.23 (73.9%) | 27.27 (100%) |
| Present study | 1.54 (1.8%) | 2.4 (50%) | 5.5 (100%) | 14.14 (100%) |
*Nondysplastic tissue includes normal, reactive, inflammation, mature and immature metaplasia, and atypical cells